Showing results (151-160 of 409) with videos related to
Sort By:
Pageof 41
Hepatology International|October 1, 2020
Thromboelastometry in patients with advanced chronic liver disease stratified by severity of portal hypertensionPierre Raeven, Joanna Baron-Stefaniak, Benedikt Simbrunner, et al.Journal of Personalized Medicine|December 24, 2021
Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19Lukas Hartl, Mathias Jachs, Benedikt Simbrunner, et al.Thrombosis and Haemostasis|May 21, 2021
Intraperitoneal Activation of Coagulation and Fibrinolysis in Patients with Cirrhosis and AscitesJohannes Thaler, Ton Lisman, Peter Quehenberger, et al.Journal of Hepatology|March 1, 2023
Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysisAntonio Guerrero, Laura Del Campo, Fabio Piscaglia, et al.United European Gastroenterology Journal|June 19, 2019
Ascitic fluid polymorphic nuclear cell count impacts on outcome of cirrhotic patients with ascitesBenedikt Simbrunner, Annika Röthenbacher, Helmuth Haslacher, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 6, 2022
Angiopoietin 2 levels decrease after HCV-cure and reflect the evolution of portal hypertensionDavid Bauer, Karin Kozbial, Philipp Schwabl, et al.Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|February 28, 2022
Point Shear Wave Elastography by ElastPQ for Fibrosis Screening in Patients with NAFLD: A Prospective, Multicenter Comparison to Vibration-Controlled ElastographyDavid Jm Bauer, Vladimir Matic, Ruxandra Mare, et al.Liver International : Official Journal of the International Association for the Study of the Liver|January 22, 2013
Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signallingThomas Reiberger, Berit Anna Payer, Philipp Schwabl, et al.JHEP Reports : Innovation in Hepatology|April 10, 2023
Dysregulated biomarkers of innate and adaptive immunity predict infections and disease progression in cirrhosisBenedikt Simbrunner, Lukas Hartl, Mathias Jachs, et al.Hepatology International|March 7, 2023
Bacterial translocation occurs early in cirrhosis and triggers a selective inflammatory responseBenedikt Simbrunner, Esther Caparrós, Teresa Neuwirth, et al.Pageof 41